TIDMCOS

RNS Number : 7679Q

Collagen Solutions PLC

02 December 2016

Collagen Solutions Plc

(the "Company" or the "Group")

Notice of Half Year Results

Analyst Briefing

The Board of Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, will announce their unaudited interim results for the six months ending 30 September 2016 on Monday, 19 December 2016.

A briefing for analysts will take place at Walbrook PR, 4 Lombard Street, London EC3V 9HD at 10.00am on Monday 19 December 2016.

If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email collagen@walbrookpr.com.

Enquiries:

 
 Collagen Solutions Plc                                                  Contact via Walbrook 
 Jamal Rushdy, Chief Executive Officer 
 Gill Black, Chief Financial Officer 
 
 Cenkos Securities plc (Nominated                                          Tel: 0207 397 8900 
  Adviser and Broker) 
  Stephen Keys 
  Steve Cox 
 
 Walbrook PR                                Tel: 020 7933 8780 or collagen@walbrookpr.com 
 Mike Wort                                                                 Mob: 07900 608 002 
 Anna Dunphy                                                               Mob: 07876 741 001

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORFSUEEFFMSEEE

(END) Dow Jones Newswires

December 02, 2016 02:01 ET (07:01 GMT)

Collagen Solutions (LSE:COS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Collagen Solutions Charts.
Collagen Solutions (LSE:COS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Collagen Solutions Charts.